Last reviewed · How we verify
Placebo of AngongNiuhuang pill — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of AngongNiuhuang pill (Placebo of AngongNiuhuang pill) — Peking Union Medical College Hospital. This is a placebo control arm in a clinical trial and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of AngongNiuhuang pill TARGET | Placebo of AngongNiuhuang pill | Peking Union Medical College Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of AngongNiuhuang pill CI watch — RSS
- Placebo of AngongNiuhuang pill CI watch — Atom
- Placebo of AngongNiuhuang pill CI watch — JSON
- Placebo of AngongNiuhuang pill alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of AngongNiuhuang pill — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-angongniuhuang-pill. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab